Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.900
+0.320 (6.99%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Basel Medical Group Balance Sheet
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.34 | 3.04 | 1.95 | 1.22 | 1.56 |
Short-Term Investments | 7.11 | 6.77 | 0.09 | 0.1 | 0.1 |
Cash & Short-Term Investments | 8.45 | 9.82 | 2.04 | 1.31 | 1.66 |
Cash Growth | -22.18% | 380.92% | 55.27% | -20.86% | - |
Accounts Receivable | 3.23 | 2.15 | 1.67 | 1.44 | 2.01 |
Other Receivables | 1.91 | 0.37 | 0.21 | 1.34 | 0.84 |
Receivables | 5.15 | 2.53 | 12.44 | 13.33 | 13.88 |
Inventory | 0.33 | 0.49 | 0.07 | 0.09 | 0.07 |
Prepaid Expenses | 0.22 | 0.43 | 0.03 | 0.04 | 0.05 |
Other Current Assets | 0.03 | 0.03 | 1.59 | - | - |
Total Current Assets | 14.18 | 13.29 | 16.17 | 14.77 | 15.67 |
Property, Plant & Equipment | 5.9 | 5.34 | 0.06 | 0.58 | 1.18 |
Long-Term Deferred Tax Assets | 0.05 | 0.05 | 0.08 | 0.03 | 0 |
Total Assets | 20.12 | 18.68 | 16.31 | 15.38 | 16.85 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.47 | 4.86 | 1.11 | 1.46 | 1.08 |
Accrued Expenses | 1.71 | 1.72 | 1.47 | 0.31 | 0.89 |
Short-Term Debt | 0.9 | 1.51 | 1.42 | - | - |
Current Portion of Long-Term Debt | 0.92 | - | 2.68 | 3.22 | 3.63 |
Current Portion of Leases | 2.02 | 2.06 | 0.03 | 0.57 | 0.57 |
Current Income Taxes Payable | - | - | 0.44 | 0.48 | 0.39 |
Other Current Liabilities | 0.51 | 0.02 | 0.02 | 0.43 | 0.63 |
Total Current Liabilities | 7.52 | 10.16 | 7.16 | 6.47 | 7.19 |
Long-Term Debt | 2.01 | - | 1.58 | 3.4 | 5.31 |
Long-Term Leases | 4.03 | 2.96 | - | 0.03 | 0.64 |
Long-Term Deferred Tax Liabilities | 0.04 | 0.12 | - | - | - |
Total Liabilities | 13.6 | 13.24 | 8.75 | 9.89 | 13.14 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 34.21 | 34.21 | 24.46 | 0 | 0 |
Retained Earnings | -3.69 | -3.85 | 7.56 | 5.49 | 3.71 |
Comprehensive Income & Other | -24.24 | -24.92 | -24.46 | - | - |
Total Common Equity | 6.28 | 5.43 | 7.56 | 5.49 | 3.71 |
Minority Interest | 0.25 | 0 | - | - | - |
Shareholders' Equity | 6.52 | 5.44 | 7.56 | 5.49 | 3.71 |
Total Liabilities & Equity | 20.12 | 18.68 | 16.31 | 15.38 | 16.85 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 9.87 | 6.53 | 5.71 | 7.21 | 10.15 |
Net Cash (Debt) | -1.42 | 3.29 | -3.67 | -5.9 | -8.49 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.85 | 2.10 | -2.71 | -4.36 | -6.27 |
Filing Date Shares Outstanding | 1.57 | 1.57 | 1.35 | 1.35 | 1.35 |
Total Common Shares Outstanding | 1.57 | 1.57 | 1.35 | 1.35 | 1.35 |
Working Capital | 6.65 | 3.13 | 9.01 | 8.31 | 8.47 |
Book Value Per Share | 4.01 | 3.47 | 5.58 | 4.05 | 2.74 |
Tangible Book Value | 6.28 | 5.43 | 7.56 | 5.49 | 3.71 |
Tangible Book Value Per Share | 4.01 | 3.47 | 5.58 | 4.05 | 2.74 |
Machinery | 1.79 | 1.83 | 0.64 | 0.63 | 0.62 |